B.M.P. Pharma Trading AG, based in Norderstedt, acts as a holding company for a corporate group specializing in the trade of pharmaceutical raw materials, food supplements, and natural substances for the cosmetics and flavor industries. The portfolio also includes dermacosmetic finished products and additives for the animal feed industry. The group employs an average of 45 people and manages its operational activities through subsidiaries such as B.M.P. Bulk Medicines & Pharmaceuticals GmbH. The company is internationally oriented and actively develops new markets, including through the establishment of a subsidiary in Mexico.
Der Handel mit pharmazeutischen Produkten und medizinischen Fertig- und Futtermittelpräparaten, soweit eine besondere Erlaubnis nicht erforderlich ist, ferner die Ausübung der Holding-Funktion gegenüber anderen Unternehmen gleichen oder ähnlichen Gegenstandes.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Kiel Local Court, HRB 6645 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Henning Nau | Vorstand | Hamburg |
Source: German Commercial Register (Handelsregister) Kiel Local Court, HRB 6645 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €1,605 | €2,880,823 | €13,430,746 | — |
| 2023 | €56 | €2,755,323 | €12,119,746 | — |
| 2022 | €1,641 | €1,571,065 | €12,288,580 | — |
| 2021 | €4,452 | €2,619,651 | €9,822,847 | — |
| 2020 | €1,264 | €171,031 | €6,925,264 | — |
| 2019 | ≤ €12M1 | — | €6,388,629 | — |
| 2018 | ≤ €12M1 | — | €6,019,356 | — |
| 2017 | small company1 | — | €5,548,933 | — |
| 2016 | small company1 | — | €5,475,398 | — |
| 2015 | small company1 | — | €5,392,419 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Sign in to download data
Source: German Commercial Register (Handelsregister) Kiel Local Court, HRB 6645 (as of 30 October 2026)
Inresa Arzneimittel GmbH
Freiburg im Breisgau · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Bursch Medizintechnik GmbH
Ahlen · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
Sebia Labordiagnostische Systeme GmbH
Mainz · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €1,696,097 | 99.7% |
| Interest & Similar | €4,729 | 0.3% |
